Funding profile · Healthcare revenue cycle software

CombineHealth

A Y Combinator company with a reported $1 million raised through April 2023 and no SEC Form D filed under its name. Here is what data aggregators, a job posting and an accelerator directory show, and what a securities filing search does not.

$1.0MTotal raised, reported by aVenture as of Apr 5, 2023
$500KMost recent round reported by aVenture, completed by Apr 5, 2023
$0Form D filings found under CombineHealth or Combine Health in SEC EDGAR
14Employees, per Tracxn, as of Jul 31, 2026

Data as of September 25, 2026. Figures drawn from third party data aggregators, not from a company announcement or a confirming SEC filing, are labeled below.

Rounds at a glance

When Round Amount Investors Source
2023 Y Combinator, Winter 2023 (W23) batch Not disclosed Y Combinator Indep. record
By Apr 5, 2023 Seed or angel round $500,000 reported Not named Aggregator
By Apr 5, 2023 Cumulative total reported $1,000,000 reported 1 institutional investor, unnamed (Tracxn) Aggregator
2023 to 2026 Any further round None found None found Not found

What the filings show

They show nothing, and that absence is itself the finding. A company name search of SEC EDGAR for “combinehealth” and for “combine health” returns no matching filer. A full text search of EDGAR for the phrases “CombineHealth” and “Combine Health” across all filing types, run September 25, 2026, returns zero hits for the exact company name and, for the spaced variant, only unrelated companies and filings that happen to contain the words “combine” and “health” near each other. No Form D naming CombineHealth as issuer, and no Form D naming an investment vehicle built around it, was found.

That does not prove no money changed hands. Regulation D exempt offerings above certain thresholds normally require a Form D within 15 days of first sale, but companies that raise instead under Section 4(a)(2), through convertible notes or SAFEs structured to avoid Regulation D, or through an accelerator’s own investment vehicle, can raise real capital without ever filing one. Y Combinator itself invests in every batch company on standardized terms that are public in form but not filed individually per company with the SEC.

Reading the funding record

  1. No Form D appears under CombineHealth’s name.A company name search and a full text search of SEC EDGAR for “CombineHealth” and “Combine Health,” run September 25, 2026, turned up no matching filer and no Form D naming the company. That does not mean no funding changed hands: money raised through SAFEs or under Section 4(a)(2) instead of Regulation D requires no Form D at all.
  2. The only dollar figures on record come from data aggregators, not filings.aVenture reports a $500,000 round completed by April 5, 2023 and a cumulative $1,000,000 raised to that date. Tracxn separately counts “1 institutional investor” without naming it. Neither figure is confirmed by a public filing or by a company funding announcement found in this research.
  3. Y Combinator involvement is independently confirmed; its terms are not.CombineHealth’s own page in Y Combinator’s company directory, and a web listing of the CEO’s LinkedIn title, place the company in the Winter 2023 batch. YC’s standard deal terms are public, but nothing found here states whether CombineHealth took the standard deal or a variant of it.
  4. Headcount kept growing without a disclosed new round.aVenture counted 8 employees in February 2024. A Bangalore, India job listing posted in mid-2026 described CombineHealth as a 12-person company. Tracxn counted 14 employees as of July 31, 2026. None of that growth is tied in the public record to a named financing event after the 2023 figures.

Commercial signals

Signal Detail Source type
Product Five named AI agents: Amy (coding), Mark (billing), Adam (denial management), Rachel (appeals) and Taylor (analytics). Company-stated
Independent evaluation 1,000 ED chart coding test, audited by outside firm Edelberg & Associates; CombineHealth reports accuracy matching or beating expert human coders on 3 of 4 measured dimensions. Company-stated
Hiring Full-time engineering role posted in Bangalore, India in mid-2026, describing CombineHealth as a 12-person company. Independent
Named customers None found; homepage and case study testimonials are unattributed. Not found

What to watch

  • A Form D, from CombineHealth itself or from an investment vehicle formed around it, which would confirm or correct the aVenture and Tracxn figures.
  • A named lead investor; none is on record anywhere found in this research.
  • Revenue or customer count disclosures tied to the 14-person headcount Tracxn reports for mid-2026.
  • Whether the Bangalore, India office grows into a second disclosed location or stays a small engineering outpost.

The CombineHealth story on Healthcare DiscoveryHealthcare Discovery

Related companies

Sources

  1. Public recordCompany name search for “combinehealth” and “combine health,” Form D filersSEC EDGAR · searched Sep 25, 2026
  2. Public recordFull text search for “CombineHealth” and “Combine Health”SEC EDGAR · searched Sep 25, 2026
  3. Indep. recordCombineHealth company page and founder biographyY Combinator · accessed 2026
  4. IndependentCombineHealth company profile, funding and employee countaVenture · accessed Jul 3, 2026
  5. IndependentCombineHealth company profile, employee count and investor countTracxn · snapshot dated 2026
  6. IndependentFull Stack Engineer job listing, CombineHealth, BangaloreCutshort · accessed Jul 28, 2026
  7. CompanyCase study: AI codes alongside ED experts, 1,000 emergency department chartsCombineHealth resources page · accessed Sep 25, 2026
  8. CompanyAbout Us pageCombineHealth · accessed Sep 25, 2026

Compiled from SEC EDGAR searches and published third party company data as of September 25, 2026. A Form D notice, where one exists, reports an offering under Regulation D; no Form D naming CombineHealth or an investment vehicle built around it was found. Healthcare Venture Capital Fund holds no position in CombineHealth. This page is not an offer to sell or a recommendation to buy any security.